IMA Clinical Research

IMA Clinical Research, founded in 2011, operates as a technology-enabled clinical research organization in the Business Services sector. The company specializes in conducting and supporting clinical trials across diverse therapeutic areas, playing a crucial role in developing new medical treatments. Its focus is on facilitating efficient, patient-centric clinical studies by connecting sponsors, CROs, healthcare providers, and patients, contributing to the healthcare innovation ecosystem.

The organization maintains a robust operational footprint with 21 locations across the United States, functioning as a network of clinical trial sites. This diverse infrastructure, including full-service, satellite, and outreach sites, enhances patient access and participation. IMA Clinical Research leverages this network to recruit participants from varied demographics, improving data quality and representativeness. With an employee range of 500-1,000 individuals, the company manages complex research initiatives. Meet IMA Clinical Research's team to understand their operational leadership.

Generating $138.6M in revenue, IMA Clinical Research competes in a dynamic market. Its offerings include phase II, phase IV studies, and general clinical research. The company's funding history includes a $176,000 debt round in February 2021. By bridging research entities and patient populations, IMA Clinical Research advances medical science. Explore financial highlights for detailed performance metrics and investment information.